Your Phase 1 Clinical Trial Specialist in Australia and the USA
Nucleus Network Nucleus Network
656 subscribers
11,250 views
0

 Published On Jun 20, 2021

Put your Phase 1 clinical trial in a safe pair of hands at Nucleus Network. Learn about the advantages Nucleus Network and Australia offer for your Phase 1 Clinical Trial. As Australia’s largest provider, we are also the world’s only multi-country and multi-site Phase 1 clinical trial specialist, offering you benefits in speed, quality, and cost.
Find us at https://www.nucleusnetwork.com

Learn about the advantages Nucleus Network and Australia offer for your Phase 1 Clinical Trial. As Australia’s largest provider, we are also the world’s only multi-country and multi-site Phase 1 clinical trial specialist, offering you benefits in speed, quality, and cost.

Headquartered in Melbourne, Australia, Nucleus Network conducts Phase 1 studies and is dedicated to advancing medicine and improving lives.

Our multi-site business offers our clients significant advantages in speed, quality, and cost, as well as providing highly experienced clinical and recruitment services. 

With the COVID-19 pandemic bringing increased public scrutiny and disrupting operations, choosing the right partner for your clinical trials is more important than ever before.

Our multi-site approach, combined with Australia’s low case numbers, ensures high-quality data reporting and minimal interruptions to the timeline.  

We work with clients of all sizes, from large multinational pharmaceutical companies to bespoke studies for start-up biotech groups. We have also been a provider of choice for Australia's Covid-19 vaccine trials. 

Quality and efficiency are the key guiding principles in our approach to Clinical Trials. Our data-driven approach is at the heart of everything we do. We also have strong familiarity and a good standing with many regulatory bodies, such as the FDA and EMA.  

Our facilities are co-located within world-class hospitals and medical research precincts. In the US, we are at the forefront of medical research into renal and hepatic investigations.

As Australia’s largest provider, we oversee approximately 65% of the local Phase 1 clinical trial market. We assist our partners to access cost benefits, optimize return on investment, and support compliance with R&D tax incentives.

We have the capability to recruit for healthy trials as well as specific patient studies from an extensive and varied pool of participants.

In a time of uncertainty, you can be sure that your trial is in a safe pair of hands at Nucleus Network.

With advantages in speed, quality, cost, and multi-site coordination, our purpose is to help our clients. Nucleus Network, advancing medicine, improving lives.

show more

Share/Embed